Track topics on Twitter Track topics that are important to you
Diabetes patients' cost-sharing is increasing as PBMs and health plans are paying less for insulin products. While this situation defies logic, it reflects an imperfect market in which it's not necessarily in the PBMs' and health plans' interests to engage in a fully competitive marketplace.
Original Article: Rising Out-Of-Pocket Costs For Insulin Indicates Market FailureNEXT ARTICLE
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...